A Recent Review on Cancer Nanomedicine
Cancers · 12.04.2023 · 15 (8) · 2256
DOI: 10.3390/cancers15082256 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 12.04.2023. Verfasst von Paras Mani Giri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, College of Health Professions, North Dakota State University, Fargo, ND 58105, USA. Die Arbeit wurde bisher 153-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences, DaCCoTA CTR pilot ready-to-go.
Abstract (Originalsprache)
Cancer is one of the most prevalent diseases globally and is the second major cause of death in the United States. Despite the continuous efforts to understand tumor mechanisms and various approaches taken for treatment over decades, no significant improvements have been observed in cancer therapy. Lack of tumor specificity, dose-related toxicity, low bioavailability, and lack of stability of chemotherapeutics are major hindrances to cancer treatment. Nanomedicine has drawn the attention of many researchers due to its potential for tumor-specific delivery while minimizing unwanted side effects. The application of these nanoparticles is not limited to just therapeutic uses; some of them have shown to have extremely promising diagnostic potential. In this review, we describe and compare various types of nanoparticles and their role in advancing cancer treatment. We further highlight various nanoformulations currently approved for cancer therapy as well as under different phases of clinical trials. Finally, we discuss the prospect of nanomedicine in cancer management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, School of Pharmacy, College of Health Professions, North Dakota State University, Fargo, ND 58105, USA.
ORCID-Profile: Buddhadev Layek
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- DaCCoTA CTR pilot ready-to-go
Zitieren
APA
Giri, P. M., Banerjee, A., & Layek, B. (2023). A Recent Review on Cancer Nanomedicine. Cancers, 15(8), 2256. https://doi.org/10.3390/cancers15082256
Vancouver
Giri PM, Banerjee A, Layek B. A Recent Review on Cancer Nanomedicine. Cancers. 2023;15(8):2256. doi:10.3390/cancers15082256
BibTeX
@article{Giri2023,
author = {Giri, Paras Mani and Banerjee, Anurag and Layek, Buddhadev},
title = {A Recent Review on Cancer Nanomedicine},
journal = {Cancers},
year = {2023},
volume = {15},
number = {8},
pages = {2256},
doi = {10.3390/cancers15082256}
}
EUVIMED